These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28945746)

  • 1. Proteasome impairment by α-synuclein.
    Zondler L; Kostka M; Garidel P; Heinzelmann U; Hengerer B; Mayer B; Weishaupt JH; Gillardon F; Danzer KM
    PLoS One; 2017; 12(9):e0184040. PubMed ID: 28945746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
    Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
    Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome.
    Emmanouilidou E; Stefanis L; Vekrellis K
    Neurobiol Aging; 2010 Jun; 31(6):953-68. PubMed ID: 18715677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.
    Tanaka Y; Engelender S; Igarashi S; Rao RK; Wanner T; Tanzi RE; Sawa A; L Dawson V; Dawson TM; Ross CA
    Hum Mol Genet; 2001 Apr; 10(9):919-26. PubMed ID: 11309365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson's Disease Models.
    Zhou H; Shao M; Guo B; Li C; Lu Y; Yang X; ShengnanLi ; Li H; Zhu Q; Zhong H; Wang Y; Zhang Z; Lu J; Lee SM
    Neurotherapeutics; 2019 Oct; 16(4):1225-1236. PubMed ID: 31313223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein.
    McKinnon C; De Snoo ML; Gondard E; Neudorfer C; Chau H; Ngana SG; O'Hara DM; Brotchie JM; Koprich JB; Lozano AM; Kalia LV; Kalia SK
    Acta Neuropathol Commun; 2020 Feb; 8(1):17. PubMed ID: 32059750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
    Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
    Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
    Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress.
    Sharma N; Brandis KA; Herrera SK; Johnson BE; Vaidya T; Shrestha R; Debburman SK
    J Mol Neurosci; 2006; 28(2):161-78. PubMed ID: 16679556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silica nanoparticles induce alpha-synuclein induction and aggregation in PC12-cells.
    Xie H; Wu J
    Chem Biol Interact; 2016 Oct; 258():197-204. PubMed ID: 27613482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation.
    Alves da Costa C; Dunys J; Brau F; Wilk S; Cappai R; Checler F
    J Biol Chem; 2006 Apr; 281(14):9824-31. PubMed ID: 16464850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of titanium dioxide nanoparticles on α-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons.
    Wu J; Xie H
    Artif Cells Nanomed Biotechnol; 2016; 44(2):690-4. PubMed ID: 25386730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.
    Ghee M; Melki R; Michot N; Mallet J
    FEBS J; 2005 Aug; 272(16):4023-33. PubMed ID: 16098186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.
    Anandhan A; Rodriguez-Rocha H; Bohovych I; Griggs AM; Zavala-Flores L; Reyes-Reyes EM; Seravalli J; Stanciu LA; Lee J; Rochet JC; Khalimonchuk O; Franco R
    Neurobiol Dis; 2015 Sep; 81():76-92. PubMed ID: 25497688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between the proteasome system and autophagy in the clearance of α-synuclein.
    Yang F; Yang YP; Mao CJ; Liu L; Zheng HF; Hu LF; Liu CF
    Acta Pharmacol Sin; 2013 May; 34(5):674-80. PubMed ID: 23603979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death.
    Sun F; Anantharam V; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
    J Pharmacol Exp Ther; 2005 Oct; 315(1):69-79. PubMed ID: 15987830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-Synuclein is degraded by both autophagy and the proteasome.
    Webb JL; Ravikumar B; Atkins J; Skepper JN; Rubinsztein DC
    J Biol Chem; 2003 Jul; 278(27):25009-13. PubMed ID: 12719433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cellular model to monitor proteasome dysfunction by alpha-synuclein.
    Nonaka T; Hasegawa M
    Biochemistry; 2009 Aug; 48(33):8014-22. PubMed ID: 19630439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of cleavage of alpha-synuclein by the 20S proteasome and modulation of its degradation by the RedOx state of the N-terminal methionines.
    Alvarez-Castelao B; Goethals M; Vandekerckhove J; Castaño JG
    Biochim Biophys Acta; 2014 Feb; 1843(2):352-65. PubMed ID: 24315858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.